1nhaler

1nhaler

Private
EdinburghHealthcare & Life Scienceshttps://www.1nhaler.com/

Last Round

Seed

Nov 17, 2025

Total Funding Raised

$4.4M

Company Overview

1nhaler is a medical device company that is a developer of a single-dose, disposable, dry-powder inhaler.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Pharma Supply Chain, Clinical Trials, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

dry-powder inhalerDPIsingle-dose inhalerdrug delivery platformdisposable inhalercardboard inhalerpop-up inhalerinhalable drug deliverysustainable medical deviceeco-friendly inhalerbreath-activated inhalermedical devicepropellant-free deliveryinhalable vaccinespublic health preparedness

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

1nhaler Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

1nhaler Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedNov 17, 2025
SeedNov 27, 2023

1nhaler Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 17, 2025

    $2M round with British Business Investments and Scottish Investment Bank.

  • Nov 27, 2023

    $2.5M raised from British Business Investments and Dr Yusuf Hamied.

1nhaler Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

1nhaler Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 1nhaler's valuation, stock price, and market status.

Firmographic Details

HeadquartersEdinburgh
Year Founded2017
Last FundingNov 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.